Ingenious Med Secures Majority Investment from North Bridge Growth Equity

ingeniousmedIngenious Med, an Atlanta, GA-based provider of a patient encounter platform, secured a majority stake investment from North Bridge Growth Equity.

The company intends to use the proceeds to expand its clinician alignment offerings.

Led by Dr. Steven Liu, founder and chief medical officer, and and S. Hart Williford, CEO and president, Ingenious Med provides a cloud-based, patient encounter platform, IM1, in the healthcare industry. The solution automates physician and care team workflow at the point of care, unifying communication, coding, revenue, and business and clinical intelligence into a integrated solution that can be accessed through mobile devices or the Web. The company currently serves 25,000 users at 900+ healthcare facilities across the U.S., including large hospitalist management companies as well as health systems.

In conjunction with the investment, North Bridge managing director, Doug Kingsley, and principal Roshen Menon are joining the Board of Directors of Ingenious Med along with George Lynn, who has more than 30 years of experience as a healthcare executive for provider organizations.



Join the discussion